NCT00204269

Three-Year Trial on a New Testosterone Gel

Three-Year Trial on a New Testosterone Gel: Clinical Efficacy, Tolerability and Compliance

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 100 (planned)
• Sponsor: University Hospital Muenster · Academic / Other
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of the study is to examine the efficacy and tolerability of a three-year-Testosterone replacement therapy in hypogonadal patients as well as the patient's compliance. The replacement therapy will be performed with a new Testosterone Gel examined in previous trials as Testosteron Gel Wolff.

Detailed description

The objective of the study is to examine the efficacy and tolerability of a three-year-Testosterone replacement therapy in hypogonadal patients as well as the patient's compliance. The replacement therapy will be performed with a new Testosterone Gel examined in previous trials as Testosteron Gel Wolff (TGW). A minimum of 100 patients will be recruited and evenly distributed to two treatment arms. 1st arm: dermal (non-scrotal) application of TGW. 2nd arm: scrotal application of TGW.

Conditions

• Hypogonadism

Interventions

Type	Name	Description
DRUG	Testosterone Gel Wolff

Timeline

• Start date: 2003-01-01
• Completion: 2006-09-01
• First posted: 2005-09-20
• Last updated: 2006-05-15

Locations

15 sites across 1 country: Germany